GlassScriptPhysician profile
Kenneth W Mcelroy
NPI 1093923005
$1,637.74
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,142 · 2022: $343 · 2023: $13.18 · 2024: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $140 · Food and Beverage: $13.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $140.00 |
| Food and Beverage | $13.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $743.10 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $374.22 | 2021-2022 | |
| Abbvie INC. | $178.05 | 2021-2022 | |
| Medtronic, INC. | $153.50 | 2021-2024 | Nuro |
| Pfizer INC. | $55.09 | 2021-2022 | |
| Harmony Biosciences LLC | $46.26 | 2022-2023 | Wakix |
| Lilly USA, LLC | $33.84 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $22.46 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.87 | 2021 | |
| Novo Nordisk INC | $12.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Mcelroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.